AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TG THERAPEUTICS, INC. Director's Dealing 2016

Jul 9, 2016

31066_dirs_2016-07-08_f9b329ef-178d-4dc3-9761-48cc930cabe3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2016-07-05

Reporting Person: Power Sean A (CFO, Secretary and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-05	COMMON STOCK	S	50426	$5.99	Disposed	416256	Direct

Footnotes

F1: In connection with the vesting of 95,833 shares on June 30, 2016, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.

F2: Represents the weighted average sales price.

F3: Includes shares of restricted Common Stock, which vest over various time periods.